​​

​​  Evening Meeting Agenda


 6:00 PM:  Industry Exhibits and Annual Holiday Mixer


​​7:30 PM: CME Program


Q & A Discussion to Follow


"Update on Prevention and Management


of Hepatitis B"​


Anna S. Lok, M.D.

Dame Sheila Sherlock Distinguished University

Professor of Hepatology and Internal Medicine
Alice Lohrman Andrews Research Professor of Hepatology, 
Professor of Internal Medicine, Assistant Dean for Clinical Research

​

University of Michigan Medical School


​​​​​What if I haven't updated my dues yet?  We encourage all members to renew their membership dues with our easy online system.  Members need to be current on Annual Memberships Dues for 2025 in order to attend most of our programs. We will be able to update your dues in person at the meeting!

Invite a new colleague as your guest. Did you know that PNWGS members can bring a guest to enjoy one PNWGS evening program for free as an introduction to our society? Take advantage of this perk. Their CME and MOC Points are always included.


​The Session Evaluation, CME Certificate, and MOC Form will be emailed to all participants after the event.


Parking is easy, and valet parking is now included with dinner at the Rainier Club Parking Garage.  You will enter the auto court of the Rainier Club on the right as you drive down Columbia Street to enter their garage.
​

The PNWGS is honored to welcome Anna S. Lok, M.D. from the University of Michigan Medical School for the third session of the 2025 "Meet the Professor" Evening Program.

​EARN CME & MOC POINTS

​​

​​​​​Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME).  


The Pacific Northwest Gastroenterology Society (PNWGS) is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The PNWGS designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity meets the criteria for up to 1.5 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.


NOTE: PNWGS offers ABIM MOC points for this activity for learners choosing to participate in the MOC program. Learners are NOT required to participate in any MOC activities in order to claim AMA PRA Category 1 Credits™ for this activity.​

MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

About the Professor ​

Anna Suk-Fong Lok, M.D. is the director of clinical hepatology and assistant dean for clinical research at the University of Michigan Medical School. She also is the Dame Sheila Sherlock Distinguished University Professor of Hepatology and Internal Medicine and Alice Lohrman Andrews Research Professor of Hepatology in the Department of Internal Medicine. In her role as assistant dean, Dr. Lok is responsible for leading, championing, and implementing recommendations from the Research Board of Directors to transform the clinical trials enterprise of the academic medical center. She is responsible for the overall leadership and direction, management, and oversight of the Clinical Trials Support Units and the Clinical Research Unit, training of clinical investigators, and facilitation and support of clinical research.
Dr. Lok obtained her medical degree from the University of Hong Kong and her hepatology training under the late Dame Sheila Sherlock at the Royal Free Hospital in London, UK. She was on the faculty at the University of Hong Kong until she moved to the United States in 1992.
 
Her research focuses on the natural history and treatment of hepatitis B and C, and the prevention of liver cancer. Her research is funded by the National Institutes of Health, federal and private foundations, and various pharmaceutical companies. She has published more than 600 papers on viral hepatitis and liver diseases and is the co-author of five editions of the American Association for the Study of Liver Diseases Association Guidelines on Hepatitis B. She was one of the top 1% most cited scientists in the world for the decade 2002-12. She has trained more than 60 fellows and junior faculty from all over the world, some of whom have risen to the ranks of full professors and directors of liver programs in their home country.
 
She received a Distinguished Mentor Award from the Michigan Institute of Clinical and Health Research in 2012, an Inspirational Physician Award from the American Medical Association in 2014, and a Distinguished Mentor Award from the American Gastroenterological Association in 2022. She was inducted into the Clinical Excellence Society in the Department of Internal Medicine in 2013.
 
Dr. Lok has received many awards throughout her career. She has been included in the list of “Best Doctors” and “Who's Who” for many years. She was inducted into the Association of American Physicians in 2012 and elected to the National Academy of Medicine in 2022. Recent awards include the Distinguished Scientist Award from the Hepatitis B Foundation in 2008, the Distinguished Women Scientist Award from the American Gastroenterological Association in 2008, the Distinguished Service Award from the American Association for the Study of Liver Diseases in 2011, the Distinguished Scientific Achievement Award from the American Liver Foundation in 2015, the William Beaumont Prize in Gastroenterology from the American Gastroenterological Association in 2016, a Gold Medal Award from the Canadian Association for the Study of the Liver and an honorary Doctor of Science degree from the University of Hong Kong in 2017, the International Recognition Award from the European Association of the Study of the Liver in 2018, and a Distinguished University Professorship from the University of Michigan in 2019.
 
She is currently an associate editor of Hepatology Communication. She was an associate editor of HEPATOLOGY from 2001-06, a co-editor of the Journal of Viral Hepatitis from 2007-09, and a senior associate editor of GASTROENTEROLOGY from 2011-12. Dr. Lok was the President of the American Association for the Study of Liver Diseases in 2017.